Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/27598
ชื่อเรื่อง: Benefits of early application of pelvic circumferential compression device to reduce bleeding in pelvic fractures
ผู้แต่ง: Rungsinaporn V.
Akkarawanit P.
Kongmalai P.
Keywords: Blood transfusion
Hematocrit change
PCCD
Pelvic binder
Pelvic fracture
วันที่เผยแพร่: 2022
สำนักพิมพ์: BioMed Central Ltd
บทคัดย่อ: Background: To study of efficacy of early pelvic circumferential compression device using in patients with suspected pelvic trauma, compared with conventional stepwise approach. Methods: Traumatic injury and at least one of the following criteria are required for inclusion: loss of consciousness or a Glasgow coma score (GCS) of less than 13; systolic blood pressure less than 90 mmHg; falling from more than 6 m; injury to several important organs; and a positive pelvic compression test. Patients who satisfied the inclusion criteria for the experimental group were given an early application of a commercial pelvic sling beginning in July 2019. The control group consisted of cases who got the device after clinical or radiological confirmation of a pelvic fracture in the previous year. Gender, age, mechanism of injury, GCS, hospital stay, amount of packed red blood cell transfusion, hematocrit in emergency room, and hematocrit 24 h after application of pelvic binder were all assessed and compared. Results: The study had a total of 30 participants, with 15 in each group. The number of packed red blood cell transfusions in the early pelvic binder group (0.80 ± 1.42) is considerably lower than in the control group (2.4 ± 2.32) (P = 0.008), although the hematocrit change is not statistically different between the groups (2.1 VS 0.7) (P = 0.191). The time it took to install a pelvic binder was considerably shorter in the early pelvic binder group (16.40 ± 5.45) than in the control group (40.40 ± 13.64) (P = 0.001). There were no problems associated to soft tissue and skin necrosis in either group of patients. Conclusions: The use of the PCCD for 24 h prior to clinical and radiographic confirmation has significantly reduced the rate of packed red blood cell transfusion in any pelvic fracture patient without device-related complications. Trial registration: The study was entered into the Thai Clinical Trials Registry (TCTR20210809007). © 2022, The Author(s).
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125688739&doi=10.1186%2fs12891-022-05166-3&partnerID=40&md5=c6b14be7e77b578e386dc3e33dbb4380
https://ir.swu.ac.th/jspui/handle/123456789/27598
ISSN: 14712474
Appears in Collections:Scopus 2022

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.